With an enabling environment and investment in research, Nigeria can produce insulin to treat diabetes and antivenom for snake and scorpion bites in commercial quantities.A Professor of Enzymology and ...

A biotech which seeks to accelerate drug discovery by providing easy access to functional proteins through its proprietary platform has extended its total Series C funding to £64.5m.

The first year of a baby’s life is full of rapid changes and exciting milestones. Babies grow really fast during this time; most double their birth weight by around 6 months, and triple it by the time ...

Nuclera’s eProtein Discovery system, which accelerates drug discovery by providing rapid, easy access to functional proteins, ...

Sherry Gu, Executive Vice President and CTO at WuXi Biologics, explains the critical challenges of developing bispecific ...

Following the installation of eProtein Discovery at leading academic institutes across the UK and Europe 1, the expansion ...

Non-coding DNA is essential for both humans and trypanosomes, despite the large evolutionary divergence between these two species.

Nuclera has expanded its Series C funding round to USD $87 million following a new USD $12 million extension led by Elevage ...

Cambridge biotech Nuclera has boosted its Series C round to $87 million after securing a further $12m from a range of backers ...

The funding will support further development of eProtein Discovery to enable full-format antibody expression, purification, ...

Additional $12M financing led by Elevage Medical Technologies and Jonathan Milner alongside existing investors British Business Bank, and GK Goh -- The funding will accelerate development of eProtein ...

Tarun Kapoor is tackling a deceptively tricky biochemical challenge: how to speed up the internal machinery of living cells.